Evidence brief · printable

Rheumatoid Arthritis evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Rheumatoid Arthritis: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/rheumatoid-arthritis.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Adalimumab 4 trials
  • Etanercept 3 trials
  • PF-04629991 3 trials
  • Sirukumab 3 trials
  • Abatacept 2 trials
  • Ianalumab (VAY736) 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • B vitamins and folate 27 trials · 23 completed · 19 with results
  • Education, coaching and self-management 48 trials · 32 completed · 4 with results
  • Psychotherapy, counselling and peer support 12 trials · 9 completed · 2 with results
  • Yoga, tai chi, qigong and pilates 11 trials · 7 completed · 2 with results
  • Vitamin D 6 trials · 6 completed · 2 with results
  • Omega-3 fatty acids and fish oil 6 trials · 4 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Omega-3 Fatty Acids
  • Vitamin E
  • N-Acetylcysteine
  • Curcumin
  • Selenium
  • Alpha-Lipoic Acid

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • Anti-CCP Antibodies higher · Matuszewska et al. 2016
  • CRP higher · Kourilovitch et al. 2014
  • ESR higher · Inciarte-Mundo et al. 2022
  • IL-6 higher · Qin et al. 2022
  • Rheumatoid Factor higher · Matuszewska et al. 2016

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE… NCT07201558
  • A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat… NCT07409103
  • Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal… NCT05003934
  • Creating Health Course Study for People With Rheumatological Conditions and Mood… NCT07180537
  • Dose Response of Exercise for Arthritis Management NCT06880653
  • Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental… NCT07222696

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 10 trials of rehabilitation and therapy services found, none measured physical function and exercise capacity 59 trials of other approaches did
  • Among 8 trials of care delivery and health services found, none measured pain 59 trials of other approaches did
  • Among 8 trials of care delivery and health services found, none measured physical function and exercise capacity 59 trials of other approaches did
  • Diet, fasting and nutrition: symptom severity and disease activity 16 trials, no results posted yet
  • Exercise and physical activity: pain 15 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (321 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.